Skip to search formSkip to main contentSkip to account menu

GPR110 wt Allele

Known as: G Protein-Coupled Receptor 110 Gene, PGR19, ADGRF1 wt Allele 
Human ADGRF1 wild-type allele is located in the vicinity of 6p12.3 and is approximately 45 kb in length. This allele, which encodes adhesion G… 
National Institutes of Health

Related topics

Related topics

4 relations
G Protein-Coupled Receptor SignalingLigand BindingReceptor SignalingSignal Transduction

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Clinicopathological and prognostic significance of aberrant G protein-couple receptor 110 (GPR110) expression in gastric cancer.
2019
2019
Metabolic studies of synaptamide in an immortalized dopaminergic cell line.
2019
2019
Abstract 3044: The role of GPR110 in tumorigenicity, tumor cell dissemination, and cell cycle regulation in HER2+ breast cancer
Identification of novel drug targets to overcome anti-HER2 therapy resistance is an unmet need. Since G protein-coupled receptors… 
2018
2018
GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancer
PurposeG protein-coupled receptors (GPCRs) represent the largest family of druggable targets in human genome. Although several… 
2017
2017
Differential expression of MUC4, GPR110 and IL2RA defines two groups of CRLF2-rearranged acute lymphoblastic leukemia patients with distinct secondary lesions.
2017
2017
Gpr110 deficiency decelerates carcinogen-induced hepatocarcinogenesis via activation of the IL-6/STAT3 pathway.
Hepatocarcinogenesis is a complex process that includes pronounced necroinflammation, unregulated hepatocyte damage, subsequent… 
2017
2017
Gpr 110 deficiency decelerates carcinogen-induced hepatocarcinogenesis via activation of the IL-6 / STAT 3 pathway
Hepatocarcinogenesis is a complex process that includes pronounced necroinflammation, unregulated hepatocyte damage, subsequent… 
2015
2015
Genome-wide expression analysis suggests a crucial role of dysregulation of matrix metalloproteinases pathway in undifferentiated thyroid carcinoma
BackgroundThyroid cancer (TC) is the most common malignant cancer of the Endocrine System. Histologically, there are three main… 
2015
2015
Targeting GPR110 in HER2-Overexpressing Breast Cancers
Abstract : Identification of drug targets with novel mechanism of actions as well as excellent safety profile is needed to… 
2013
2013
Abstract P6-04-05: GPR110 overexpression increases tumorigenic potential of HER2+ breast cancer cells
Human epidermal growth factor receptor-2-overexpressing (HER2+) breast cancer is an aggressive tumor. Despite the clinical… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)